Last reviewed · How we verify
NCT06897553
ACT for Mental Health in Neurological Disorders
NA trial testing ACT-based group therapy in Neurological Disorders in 44 participants. Currently enrolling.
31 August 2026
Quick facts
| Lead sponsor | Bielefeld University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 1 December 2024 |
| Primary completion | 31 August 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- ACT-based group therapy
Conditions studied
- Neurological Disorders — all drugs for Neurological Disorders →
- Mental Health — all drugs for Mental Health →
- Executive Function (Cognition) — all drugs for Executive Function (Cognition) →
- Depression/Anxiety — all drugs for Depression/Anxiety →
Sponsor
Bielefeld University
Who can join
18 and older, any sex, with Neurological Disorders or Mental Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to examine the efficacy of this manual for mental health in people with mixed neurological disorders, including post-COVID. These conditions are often associated with cognitive impairment, which may hamper the effects of psychoterapy. Executive functioning and especially the ability to abstract thinking may be useful for individuals using Acceptance and Commitment Therapy. Therefore, the main questions research questions are: * Is this intervention effective in improving mental health? * Do executive functions predict the extent of social participation and mental health at the end of therapy? Participants will take part in 8 weekly group therapy sessions of 100 minutes each.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06897553
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ACT-based group therapy
Trials testing the same drug.
- NCT03341364 — Acceptance and Commitment Based Group Therapy for Cancer Patients · NA · withdrawn
Other recruiting trials for Neurological Disorders
Currently open trials in the same condition.
- NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality · recruiting
- NCT07384143 — Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders · NA · recruiting
Other Bielefeld University trials
Trials by the same sponsor.
- NCT06369025 — Preventing Physical and Emotional Violence by Parents and Teachers in Public Schools in Tanzania (ICC-T/ICC-P_Tanz) · NA · completed
- NCT06282029 — ACT-group for Stroke Survivors (Pilot Study) · NA · completed
- NCT04261244 — NeoRad Breast Cancer Study · Phase 3 · recruiting
- NCT05081622 — Preventing Violence by Teachers in Primary Schools in Haiti · NA · completed
- NCT04948580 — Preventing Violence by Teachers Against Children in Sub-Saharan Africa · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06897553 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bielefeld University
- Last refreshed: 27 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06897553.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing